Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.41 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | RORC | P51449 | 1/20 | 0.39 |
| ▸ | G6PD | P11413 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | STAT3 | P40763 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1494127 | 0.92 | LMNA (0.53) | LMNAGAANPC1P2RX3P2RX2 | |
| SCHEMBL3643059 | 0.84 | LMNA (0.41) | LMNAGAANPC1SLC6A2TAAR1 | |
| SCHEMBL19364055 | 0.84 | GAA (0.47) | LMNAGAAG6PDTRPA1CHRM1 | |
| SCHEMBL12781816 | 0.82 | GAA (0.52) | LMNAGAANPC1P2RX3P2RX2 | |
| SCHEMBL13683167 | 0.79 | P2RX3 (0.43) | LMNAGAANPC1P2RX3P2RX2 | |
| SCHEMBL10702604 | 0.79 | LMNA (0.72) | LMNAGABRA1GABRB1THRBALDH1A1 | |
| SCHEMBL15218613 | 0.78 | LMNA (0.44) | LMNAGAAG6PDTRPA1CHRM1 | |
| SCHEMBL14039591 | 0.78 | NPC1 (0.52) | GAANPC1P2RX3P2RX2THRB | |
| SCHEMBL7792597 | 0.77 | NPC1 (0.56) | GAANPC1HPGDTAAR1HTT | |
| SCHEMBL21686455 | 0.77 | LMNA (0.69) | LMNAGABRA1GABRB1THRBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1481730-B1 | Process for the production of phenolic compounds using zeolite beta of the proton-type, | UBE INDUSTRIES (JP) | 2008-01-23 | — | — | EP | disclosed |
| US-7285688-B2 | Proton type β zeolite, preparation method thereof and process for preparing phenol compound using the same | UBE INDUSTRIES, LTD. (JP) | 2007-10-23 | — | — | US | disclosed |
| CN-1572368-A | Novel proton type beta zeolite, preparation method thereof and process for preparing phenol compound using the same | UBE INDUSTRIES (JP) | 2005-02-02 | — | — | CN | disclosed |
| US-20040242938-A1 | Novel proton type beta zeolite, preparation method thereof and process for preparing phenol compound using the same | UBE INDUSTRIES, LTD. (JP) | 2004-12-02 | — | — | US | disclosed |
| EP-1481730-A1 | New zeolite beta of the proton-type, process for its preparation and production of phenolic compounds using the same | Ube Industries, Ltd. (JP) | 2004-12-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242938-A1 | Novel proton type beta zeolite, preparation method thereof and process for preparing phenol compound using the same | HPD, PAH, TPSD1 | LMNA 1681/4885GAA 156/4885NPC1 2174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.